Impact of family physicians on cervical cancer screening: cross-sectional questionnaire-based survey in a region of southern Poland.
Adult
Cross-Sectional Studies
Female
Health Knowledge, Attitudes, Practice
Humans
Logistic Models
Middle Aged
Multivariate Analysis
Papanicolaou Test
Patient Acceptance of Health Care
/ statistics & numerical data
Physicians, Family
Poland
/ epidemiology
Primary Health Care
/ statistics & numerical data
Surveys and Questionnaires
Uterine Cervical Neoplasms
/ diagnosis
Vaginal Smears
/ statistics & numerical data
cancer
cancer epidemiology
cancer: cervix
general practice
health behaviour
preventive medicine
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
30 08 2019
30 08 2019
Historique:
entrez:
2
9
2019
pubmed:
2
9
2019
medline:
15
9
2020
Statut:
epublish
Résumé
Despite worldwide efforts in encouraging routine pap smears for early detection of cervical cancer, Poland's screening rate lags behind the rest of the European Union at 20.2%. Family physicians (FPs) in Poland rarely perform pap smears, and little is known about the experiences and attitudes of Polish patients regarding pap smear screening in a primary healthcare (PHC) setting. A cross-sectional questionnaire-based survey was performed. Questionnaires were distributed among 43 FPs and 418 of their patients in one Polish region. The data from patients were associated with the doctors' characteristics. Descriptive statistics, the χ Nearly two-thirds of patients (66%) declared willingness to undergo free pap smear screening by their FPs, with the most common reason being time saved. Among those objecting to receive pap smears from their FPs, immediate specialist care provided by gynaecologists in case of adverse results was the main concern. The factors that positively influenced the patients' decision to undergo cervical cancer screening in PHC were: (1) living in a city with more than 100 000 inhabitants, (2) being single, (3) having a female FP or (4) a physician with specialty training in family medicine. There is high level of acceptance for pap smears performed in PHC offices among patients in Poland. They are more likely to comply with the screening due to easy access. Establishing a solid physician-patient relationship is also crucial in encouraging screening.
Sections du résumé
BACKGROUND
Despite worldwide efforts in encouraging routine pap smears for early detection of cervical cancer, Poland's screening rate lags behind the rest of the European Union at 20.2%. Family physicians (FPs) in Poland rarely perform pap smears, and little is known about the experiences and attitudes of Polish patients regarding pap smear screening in a primary healthcare (PHC) setting.
METHODS
A cross-sectional questionnaire-based survey was performed. Questionnaires were distributed among 43 FPs and 418 of their patients in one Polish region. The data from patients were associated with the doctors' characteristics. Descriptive statistics, the χ
RESULTS
Nearly two-thirds of patients (66%) declared willingness to undergo free pap smear screening by their FPs, with the most common reason being time saved. Among those objecting to receive pap smears from their FPs, immediate specialist care provided by gynaecologists in case of adverse results was the main concern. The factors that positively influenced the patients' decision to undergo cervical cancer screening in PHC were: (1) living in a city with more than 100 000 inhabitants, (2) being single, (3) having a female FP or (4) a physician with specialty training in family medicine.
CONCLUSION
There is high level of acceptance for pap smears performed in PHC offices among patients in Poland. They are more likely to comply with the screening due to easy access. Establishing a solid physician-patient relationship is also crucial in encouraging screening.
Identifiants
pubmed: 31473624
pii: bmjopen-2019-031317
doi: 10.1136/bmjopen-2019-031317
pmc: PMC6720140
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e031317Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Clin Pathol. 2002 Apr;55(4):244-65
pubmed: 11919208
Nat Rev Cancer. 2002 May;2(5):342-50
pubmed: 12044010
J Med Screen. 2002;9(2):86-91
pubmed: 12133929
N Engl J Med. 2002 Nov 21;347(21):1645-51
pubmed: 12444178
N Engl J Med. 2003 Feb 6;348(6):518-27
pubmed: 12571259
Br J Cancer. 2003 Jul 7;89(1):101-5
pubmed: 12838308
Lancet. 2004 Jul 17-23;364(9430):249-56
pubmed: 15262102
Int J Cancer. 2006 Sep 1;119(5):1095-101
pubmed: 16586444
Nat Rev Cancer. 2006 Oct;6(10):753-63
pubmed: 16990853
Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S4-7
pubmed: 18760711
BMC Health Serv Res. 2008 Dec 01;8:245
pubmed: 19046443
Women Health. 2009 Mar-May;49(2-3):246-61
pubmed: 19533513
Ann Intern Med. 2009 Nov 3;151(9):602-11
pubmed: 19884621
Virol J. 2011 Jun 03;8:269
pubmed: 21635792
BMJ. 2012 Mar 01;344:e900
pubmed: 22381677
J Infect Dis. 2013 Aug 1;208(3):385-93
pubmed: 23785124
World J Clin Oncol. 2014 Oct 10;5(4):744-52
pubmed: 25302174
J Low Genit Tract Dis. 2016 Apr;20(2):135-8
pubmed: 26735148
Prev Med. 2017 Jan;94:31-39
pubmed: 27894911
Public Health. 2018 Mar;156:79-86
pubmed: 29408192
J Womens Health (Larchmt). 2018 Jul;27(7):933-938
pubmed: 29583084
Eur J Gynaecol Oncol. 2017;38(1):69-75
pubmed: 29767868